Rye Brook Capital »

Vaneck Vectors Pharmaceutical etf shares owned by Rye Brook Capital

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Rye Brook Capital from 13F filings

Historical chart of Rye Brook Capital investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Rye Brook Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Rye Brook Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $7.4M 67k 109.36

More positions owned by Rye Brook Capital

Invesco Qqq Trust Series 1 Etf (QQQ)
Sprott Physical Uranium Tr Etf (SRUUF)
Vaneck Semiconductor Etf Etf (SMH)
Ss Industrial Select Sector Etf (XLI)
Vaneck Pharmaceutical Etf Etf (PPH)
Nexgen Energy (NXE)
Kraneshares Csi China Intern Etf (KWEB)
St Sr Utl Sl Se Spdr Etf-usd Etf (XLU)
Ss Materials Select Sector Etf (XLB)
Spdr Gold Shares Etf (GLD)
Ss Financial Select Sector Etf (XLF)
St. Joe Company (JOE)
Bloom Energy Corp (BE)
Amazon (AMZN)
Four Corners Ppty Tr (FCPT)

View all positions for Rye Brook Capital

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
UBS Group
Healthcare Of Ontario Pension Plan Trust Fund
Bnp Paribas Arbitrage, Snc
J.Safra Asset Management
Susquehanna International
Avalon Trust
Citigroup
Morgan Stanley
Adamsbrown Wealth Consultants
LPL Financial
Miller Investment Management
Royal Bank of Canada
Bank of America Corporation
Rye Brook Capital

View all funds holding Vaneck Vectors Pharmaceutical etf